Cargando…
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
BACKGROUND: This manuscript describes the genetic features of SARS-CoV-2 mutations, prevalent phylogenetic lineages, and the disease severity amongst COVID-19-vaccinated individuals in a tertiary cancer hospital during the second wave of the pandemic in Mumbai, India. METHODS: This observational stu...
Autores principales: | Shetty, Arusha, Chatterjee, Gaurav, Rajpal, Sweta, Srivastava, Tuhina, Gardi, Nilesh, Mirgh, Sumeet, Gokarn, Anant, Punatar, Sachin, Shetty, Nitin, Joshi, Amit, Nair, Sudhir, Murthy, Vedang, Khattry, Navin, Tembhare, Prashant, Dikshit, Rajesh, Chaturvedi, Pankaj, More, Ashwini, Kamtalwar, Sujeet, Chavan, Preeti, Bhat, Vivek, Patil, Amar, Dhumal, Sachin, Bhat, Prashant, Subramanian, Papagudi, Gujral, Sumeet, Badwe, Rajendra, Patkar, Nikhil, Gupta, Sudeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159196/ https://www.ncbi.nlm.nih.gov/pubmed/35685574 http://dx.doi.org/10.1155/2022/2449068 |
Ejemplares similares
-
P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.
por: Bhide, Aniket, et al.
Publicado: (2023) -
SARS-CoV2 Infection in Hematopoietic Stem Cell Transplant recipients: A Case Series from a Tertiary Cancer Centre in India
por: Rajendra, Akhil, et al.
Publicado: (2021) -
SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study
por: Dhumal, Sachin, et al.
Publicado: (2022) -
Clinical characteristics, laboratory parameters and outcomes of COVID‐19 in cancer and non‐cancer patients from a tertiary Cancer Centre in India
por: Mirgh, Sumeet P., et al.
Publicado: (2021) -
PB1949: ROLE OF LAIR1 (CD305) IN FLOW CYTOMETRIC DETECTION OF OCCULT BONE MARROW INVOLVEMENT IN NON-CLL B-CELL NON-HODGKIN LYMPHOMA
por: Ghogale, Sitaram, et al.
Publicado: (2023)